A CJC-1295 stack pairs the GHRH analog with ipamorelin, sermorelin, or tesamorelin. Learn how these stacks work, DAC vs. no DAC, risks, and legal status.
A CJC-1295 stack is a combination of the growth hormone-releasing hormone (GHRH) analog CJC-1295 with one or more other peptides, most commonly ipamorelin, sermorelin, or tesamorelin. The goal is to amplify natural growth hormone (GH) pulses for recovery, body composition, or anti-aging research. CJC-1295 is not FDA-approved for general human use, and adding other peptides does not change its legal or safety profile.
What Is a CJC-1295 Stack?
CJC-1295 is a synthetic analog of GHRH. It binds to GHRH receptors in the pituitary gland and stimulates the release of growth hormone. When paired with a ghrelin receptor agonist—often called a GH secretagogue—the two compounds can act on different pathways that control GH release.
Researchers and some athletes use the term stack to describe this pairing. A stack is not a single product; it is a protocol that combines separate peptides, each with its own dose, timing, and side effect profile. The most studied pairing is CJC-1295 with ipamorelin, but other combinations exist.
Common CJC-1295 Stacking Partners
Different peptides bring different receptor activity and half-lives to a stack. The table below compares the most frequently discussed options.
| Peptide | Class | Typical Stacking Role | Key Notes |
|---|---|---|---|
| Ipamorelin | Ghrelin receptor agonist | Adds a GH pulse with minimal cortisol or appetite effects | Short half-life; often injected 2–3 times daily |
| Sermorelin | GHRH analog | Stimulates pituitary GH release | Shorter half-life than CJC-1295 with DAC; FDA-approved for diagnostic use only |
| Tesamorelin | GHRH analog | Prescribed for visceral fat reduction in some conditions | FDA-approved for HIV-associated lipodystrophy, not for general weight loss |
| GHRP-2 / GHRP-6 | Ghrelin receptor agonists | Strong GH release | Can increase hunger and cortisol more than ipamorelin |
| Mod GRF(1-29) | GHRH analog | Same receptor target as CJC-1295 without DAC | Very short half-life; requires frequent dosing |
A popular research combination is the cjc 1295 ipamorelin tesamorelin stack, which pairs a GHRH analog with a ghrelin agonist and another GHRH analog. Another option is a sermorelin and cjc-1295 stack, which some people choose for a shorter-acting GHRH signal.
CJC-1295 With DAC vs. Without DAC
The acronym DAC stands for Drug Affinity Complex. It changes how long CJC-1295 stays active in the body. This difference matters for dosing schedules and for interpreting research results.
| Version | Half-Life | Dosing Frequency | Practical Implication |
|---|---|---|---|
| With DAC | About 6–8 days | Once weekly or every few days | Creates a sustained GH elevation rather than sharp pulses |
| Without DAC | About 30 minutes | Multiple times daily | Mimics natural pulsatile GH release more closely |
The version known as cjc-1295 with drug affinity complex was designed to extend the peptide’s life by binding to albumin in the blood. The version known as cjc-1295 without drug affinity complex is often called Mod GRF(1-29). Neither version is approved by the FDA for general human use.
Why Stack CJC-1295 With Other Peptides?
Growth hormone release is controlled by several inputs. GHRH tells the pituitary to release GH, while ghrelin-like peptides amplify that signal. Stacking a GHRH analog with a ghrelin agonist can produce a larger GH pulse than either compound alone in some studies.
Another reason for stacking is to balance side effects. Ipamorelin is often chosen because it does not raise cortisol or prolactin as much as older GHRPs. Tesamorelin is sometimes added for its studied effects on visceral fat, though it is a prescription drug with its own risks.
People interested in fat loss sometimes compare aod-9604 vs cjc-1295 ipamorelin. AOD-9604 is a fragment of human growth hormone that targets fat metabolism, while CJC-1295 and ipamorelin work upstream by increasing GH release. These are different mechanisms and should not be treated as interchangeable.
Risks, Side Effects, and Legal Status
CJC-1295 and the peptides commonly stacked with it are not FDA-approved for general human use. Sermorelin is approved only for diagnostic testing, and tesamorelin is approved only for HIV-associated lipodystrophy. Buying these peptides online for personal use is illegal in the United States without a prescription, and the products may be counterfeit or impure.
Reported side effects of CJC-1295 stacks include:
- Injection site pain, redness, or swelling
- Water retention and swelling in the hands or feet
- Joint pain or stiffness
- Fatigue or lethargy
- Headache
- Increased hunger, especially with GHRP-6
- Possible changes in blood sugar or insulin sensitivity
Long-term safety data in healthy adults are limited. Growth hormone and GH-releasing peptides can affect blood sugar, fluid balance, and possibly tumor growth in susceptible individuals. Anyone considering these compounds should talk with a licensed healthcare professional first.
How to Evaluate Research on CJC-1295 Stacks
Not all studies use the same peptide, dose, or schedule. When reading research or online claims, ask these questions:
- Did the study use CJC-1295 with DAC or without DAC?
- What dose was used, and how often was it given?
- Was there a placebo or control group?
- Were the participants healthy adults, athletes, or people with a medical condition?
- Were side effects reported and monitored?
Animal studies and small human trials cannot prove that a stack is safe or effective for general use. Anecdotal reports from forums are not clinical evidence. The absence of reported side effects in one person does not mean the protocol is risk-free.
The Bottom Line on CJC-1295 Stacks
A CJC-1295 stack is a research-oriented combination of peptides designed to increase growth hormone signaling. The most common pairings use ipamorelin, sermorelin, or tesamorelin, and the choice between CJC-1295 with DAC and without DAC changes dosing and GH pulse patterns.
These products are not approved for general human use in the US, and they carry real risks. If you have questions about growth hormone, body composition, or recovery, consult a physician rather than self-experimenting with unregulated peptides.
Frequently Asked Questions
What is the best peptide to stack with CJC-1295?
Ipamorelin is the most commonly discussed partner because it stimulates GH release with less impact on cortisol or appetite than older GHRPs. Sermorelin and tesamorelin are also used, but each has a different half-life and approval status. No stack is FDA-approved for general human use.
Is CJC-1295 with DAC or without DAC better for stacking?
Neither version is better in an absolute sense. CJC-1295 with DAC lasts about 6–8 days and is dosed infrequently, while CJC-1295 without DAC lasts about 30 minutes and mimics natural pulses. The right choice depends on the research question, not on marketing claims.
Is a CJC-1295 stack legal in the US?
No. CJC-1295 is not FDA-approved for human use, and buying it without a prescription is illegal. Sermorelin and tesamorelin have narrow approved uses, but neither is approved for general anti-aging or body composition purposes.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.